Nrf2 is a key regulator of metabolism in cancer cells: Cancer cells acquire a resistance to oxidative, metabolic, and therapeutic insults through Nrf2/Keap1 signaling, which results in cytoprotective responses [124]. This evidence concerns the gene NFE2L2 and cancer.